loading
Caribou Biosciences Inc stock is traded at $2.545, with a volume of 1.93M. It is up +9.62% in the last 24 hours and up +37.17% over the past month. Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies.
See More
Previous Close:
$2.34
Open:
$2.3
24h Volume:
1.93M
Relative Volume:
1.99
Market Cap:
$211.45M
Revenue:
$34.48M
Net Income/Loss:
$-102.07M
P/E Ratio:
-1.3984
EPS:
-1.82
Net Cash Flow:
$-104.90M
1W Performance:
+32.90%
1M Performance:
+37.17%
6M Performance:
-31.96%
1Y Performance:
-38.64%
1-Day Range:
Value
$2.295
$2.58
1-Week Range:
Value
$1.865
$2.58
52-Week Range:
Value
$1.50
$8.33

Caribou Biosciences Inc Stock (CRBU) Company Profile

Name
Name
Caribou Biosciences Inc
Name
Phone
510-982-6030
Name
Address
2929 7TH STREET, SUITE 105, BERKELEY
Name
Employee
137
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CRBU's Discussions on Twitter

Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-11-23 Initiated Truist Buy
Feb-18-22 Initiated RBC Capital Mkts Outperform
Dec-01-21 Initiated Oppenheimer Outperform
Nov-30-21 Initiated H.C. Wainwright Buy
Nov-15-21 Upgrade Citigroup Neutral → Buy
Aug-17-21 Initiated BofA Securities Buy
Aug-17-21 Initiated Citigroup Neutral
Aug-17-21 Initiated SVB Leerink Outperform
View All

Caribou Biosciences Inc Stock (CRBU) Latest News

pulisher
06:10 AM

Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares Bounce 25% But Its Business Still Trails The Industry - Simply Wall St

06:10 AM
pulisher
02:12 AM

Vanguard Group Inc's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

02:12 AM
pulisher
Oct 31, 2024

Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock? - Insider Monkey

Oct 31, 2024
pulisher
Oct 30, 2024

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey

Oct 30, 2024
pulisher
Oct 22, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Exchange Traded Concepts LLC - Defense World

Oct 22, 2024
pulisher
Oct 17, 2024

STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Oct 17, 2024
pulisher
Oct 17, 2024

Following a 49% decline over last year, recent gains may please Caribou Biosciences, Inc. (NASDAQ:CRBU) institutional owners - Simply Wall St

Oct 17, 2024
pulisher
Oct 16, 2024

Its Stock Has Paid Off Big Time For Caribou Biosciences Inc - SETE News

Oct 16, 2024
pulisher
Oct 15, 2024

How to interpret Caribou Biosciences Inc (CRBU)’s stock chart patterns - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 5.56 Increase, Closing at 1.90 - The Dwinnex

Oct 14, 2024
pulisher
Oct 10, 2024

Dimensional Fund Advisors LP Has $4.30 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

A better buy-in window may exist right now for Caribou Biosciences Inc (CRBU) - SETE News

Oct 09, 2024
pulisher
Oct 08, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Purchased by Green Alpha Advisors LLC - Defense World

Oct 08, 2024
pulisher
Oct 08, 2024

Caribou Biosciences Inc (CRBU) presents a great opportunity, but the stock is slightly undervalued - US Post News

Oct 08, 2024
pulisher
Oct 07, 2024

Analyzing Ratios: Caribou Biosciences Inc (CRBU)’s Financial Story Unveiled - The Dwinnex

Oct 07, 2024
pulisher
Oct 06, 2024

Susquehanna Fundamental Investments LLC Sells 91,637 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Oct 06, 2024
pulisher
Oct 05, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by American Century Companies Inc. - Defense World

Oct 05, 2024
pulisher
Oct 03, 2024

Point72 DIFC Ltd Purchases 23,995 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Point72 Asset Management L.P. Decreases Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat

Oct 03, 2024
pulisher
Oct 03, 2024

Point72 Asset Management L.P. Sells 1,241,478 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Oct 03, 2024
pulisher
Oct 02, 2024

1,482,900 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Bought by Renaissance Technologies LLC - Defense World

Oct 02, 2024
pulisher
Oct 01, 2024

31,831 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Purchased by Point72 Asia Singapore Pte. Ltd. - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Taking on analysts’ expectations and winning: Caribou Biosciences Inc (CRBU) - SETE News

Oct 01, 2024
pulisher
Sep 30, 2024

Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 2.06 Increase, Closing at 1.98 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Caribou Biosciences Inc (CRBU) presents a great opportunity, but the stock is slightly overvalued - US Post News

Sep 30, 2024
pulisher
Sep 30, 2024

Caribou Biosciences: CB-010, chRDNA Technology Continue To Show Promise In Gene Editing - Seeking Alpha

Sep 30, 2024
pulisher
Sep 29, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Acquired by Point72 DIFC Ltd - Defense World

Sep 29, 2024
pulisher
Sep 27, 2024

Wall Street SWOT: Caribou Biosciences stockInnovative biotech with HLA-matching focus - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

CRISPR and CRISPR-Associated (Cas) Genes Market 2024 Business Standards and Competition Landscape 2032 – Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics – Cauverynews - Cauverynews

Sep 27, 2024
pulisher
Sep 26, 2024

Stocks of Caribou Biosciences Inc (CRBU) are poised to climb above their peers - SETE News

Sep 26, 2024
pulisher
Sep 25, 2024

CRBUCaribou Biosciences, Inc. Latest Stock News & Market Updates - StockTitan

Sep 25, 2024
pulisher
Sep 25, 2024

Caribou Biosciences to Present Preclinical Data Supporting Development of CB-010 for Lupus at the American College of Rheumatology Convergence 2024 - StockTitan

Sep 25, 2024
pulisher
Sep 25, 2024

Bank of New York Mellon Corp Buys 38,098 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

How Analyst Ratings Affect Caribou Biosciences Inc Inc. (CRBU) Price Performance - The InvestChronicle

Sep 24, 2024
pulisher
Sep 23, 2024

Metric Deep Dive: Understanding Caribou Biosciences Inc (CRBU) Through its Ratios - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Are Caribou Biosciences Inc’shares a good deal? - US Post News

Sep 23, 2024
pulisher
Sep 18, 2024

A closer look at Caribou Biosciences Inc (CRBU) is warranted - US Post News

Sep 18, 2024
pulisher
Sep 18, 2024

Upward Trajectory: Caribou Biosciences Inc (CRBU) Posts a Gaine, Closing at 2.10 - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

With 60% ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) boasts of strong institutional backing - Yahoo Finance

Sep 18, 2024
pulisher
Sep 17, 2024

7 Top Gene-Editing Stocks to Buy | Investing - U.S News & World Report Money

Sep 17, 2024
pulisher
Sep 16, 2024

Take off with Caribou Biosciences Inc (CRBU): Get ready for trading - SETE News

Sep 16, 2024
pulisher
Sep 11, 2024

Check Out Caribou Biosciences Inc (CRBU)’s Trade Data Rather Than the Analysts’ Views - SETE News

Sep 11, 2024
pulisher
Sep 11, 2024

Candriam S.C.A. Has $1.03 Million Stake in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

Candriam S.C.A. Sells 520,000 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World

Sep 11, 2024
pulisher
Sep 10, 2024

Should investors be concerned about Caribou Biosciences Inc (CRBU)? - US Post News

Sep 10, 2024
pulisher
Sep 10, 2024

Global Genetic Engineering Market Size To Worth USD 8.95 Billion By 2033 | CAGR Of 20.82% - GlobeNewswire Inc.

Sep 10, 2024
pulisher
Sep 10, 2024

Vir Biotechnology Appoints Jason O’Byrne as Chief Financial Officer - StockTitan

Sep 10, 2024
pulisher
Sep 09, 2024

Balance Sheet Breakdown: Caribou Biosciences Inc (CRBU)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 09, 2024
pulisher
Sep 09, 2024

Caribou Biosciences, Inc. Announces Resignation of Jason O?Byrne as Chief Financial Officer, Effective September 27, 2024 - Marketscreener.com

Sep 09, 2024
pulisher
Sep 06, 2024

Here's Why We're Watching Caribou Biosciences' (NASDAQ:CRBU) Cash Burn Situation - Simply Wall St

Sep 06, 2024
pulisher
Sep 05, 2024

Check out these key findings about Caribou Biosciences Inc (CRBU) - SETE News

Sep 05, 2024

Caribou Biosciences Inc Stock (CRBU) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.30
price up icon 1.75%
$75.59
price down icon 0.20%
$374.10
price down icon 0.29%
$52.67
price down icon 0.85%
$207.67
price up icon 0.20%
$108.59
price up icon 0.02%
Cap:     |  Volume (24h):